MedPath

Immunogenicity and short term reactogencity of cellular DTP vaccine in Iranian childre

Not Applicable
Conditions
DTP.
Need for immunization against diphtheria-tetanus-pertussis, combined [DTP]
Registration Number
IRCT138902072471N2
Lead Sponsor
Deputy of food and drugs, Ministry of Health and Medical Education
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
600
Inclusion Criteria

Healthy children
Exclusion criteria: Incomplete vaccination card, immunodeficiency disease, severe asthma and allergy

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Antibody response against Diphtheria, Tetanus and Pertussis. Timepoint: one month. Method of measurement: ELISA.
Secondary Outcome Measures
NameTimeMethod
Comparison DTP vaccine reactogencity. Timepoint: Immediate after vaccine. Method of measurement: Checking by parents.
© Copyright 2025. All Rights Reserved by MedPath